Status:
ENROLLING_BY_INVITATION
WeChat-Based Digital Therapy to Improve Fluid Intake in Kidney Stone Patients: Study Protocol
Lead Sponsor:
The University of Hong Kong
Collaborating Sponsors:
Shenzhen Qianhai Shekou Free Trade Zone Hospital
Conditions:
Urinary Calculi
Postoperative Care
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn Whether the WeChat-based applet works to prevent urinary calculi for postoperative patients. The main questions it aims to answer are: Dose the WeChat-base...
Detailed Description
The study outcomes will be reported to adhere to the guidelines outlined in the Consolidated Standards of Reporting Trials (CONSORT) 2010 statements. Reporting measures of central tendency (mean, medi...
Eligibility Criteria
Inclusion
- With a history of urinary calculi and having received urolithiasis surgery before
- 24-hour fluid intake \< 2500 ml
- Age ≥ 18 years old
- Able to use WeChat daily
- Able to read and write informed consent
Exclusion
- Participants with obstructive uropathy, chronic urosepsis, renal failure, and renal tubular acidosis
- Participants with congestive heart failure, psychiatric conditions, pregnancy, and primary hyperparathyroidism
- Participants experienced complicated urolithiasis surgery.
- History of recurrent UTI (urinary tract infection) (\>3/year)
- Medication use increases stone risk.
- Participants with physical disabilities
Key Trial Info
Start Date :
March 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
148 Patients enrolled
Trial Details
Trial ID
NCT06990672
Start Date
March 1 2025
End Date
December 31 2025
Last Update
May 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shenzhen Qianhai Shekou Free Trade Zone Hospital
Shenzhen, Guangdong, China, 51800